cystatin F Activators
Cystatin F activators represent a group of chemical compounds that are characterized by their ability to modulate the activity of cystatin F, a member of the cystatin superfamily of cysteine protease inhibitors. Cystatin F, also known as leukocystatin, is distinctive among cystatins for its intracellular localization and role in regulating the activity of cysteine proteases within immune cells such as natural killer cells and T lymphocytes.
The activation of cystatin F can occur through direct or indirect mechanisms. Direct activation typically involves chemical agents that bind to cystatin F and induce a structural change that increases its affinity or specificity for target proteases. These changes can enhance the inhibitory function of cystatin F, leading to more effective regulation of protease activity within the cell. These biochemical interactions may involve alterations in the protein's conformation, which can affect its distribution within the cell, its secretion, or its ability to form dimers, which have been suggested to be the active form of the inhibitor. Indirect activators may work through various intracellular signaling pathways to upregulate the expression of cystatin F, modify its post-translational processing, or affect its trafficking within the cell. For example, a compound that enhances the transcription of the CST7 gene, which encodes cystatin F, would result in increased protein levels and activity. Similarly, agents that prevent the degradation of cystatin F would extend its functional presence within the cell, thereby potentially increasing the overall protease inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator. JNK activation can stimulate the translocation of various nuclear factors, which can influence the expression or activity of cystatin F if it's a target of these factors. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an ER stress inducer that triggers the unfolded protein response (UPR). If cystatin F is part of the UPR or is regulated by it, this can potentially enhance its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which can indirectly activate the AMPK pathway. If cystatin F is involved in the AMPK pathway or is regulated by it, this can potentially enhance its activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR is an AMP-activated protein kinase (AMPK) activator. If cystatin F is involved in the AMPK pathway or is regulated by it, AICAR can potentially enhance its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor which can indirectly activate autophagy. If cystatin F is involved in autophagy or is regulated by it, this can potentially enhance its activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a SIRT1 activator. If cystatin F is involved in the SIRT1 pathway or is regulated by it, Resveratrol can potentially enhance its activity. | ||||||
Metformin-d6, Hydrochloride | 1185166-01-1 | sc-218701 sc-218701A sc-218701B | 1 mg 5 mg 10 mg | $292.00 $822.00 $1540.00 | 1 | |
Metformin is an AMPK activator. If cystatin F is involved in the AMPK pathway or is regulated by it, Metformin can potentially enhance its activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin is an ER stress inducer that triggers the unfolded protein response (UPR). If cystatin F is part of the UPR or is regulated by it, this can potentially enhance its activity. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor which can indirectly increase the levels of various proteins. If cystatin F is degraded by the proteasome, MG132 can potentially increase its levels and activity. | ||||||
SB202190 hydrochloride | 350228-36-3 | sc-222294 sc-222294A | 1 mg 5 mg | $131.00 $505.00 | 13 | |
SB202190 is a p38 MAPK inhibitor which can indirectly activate the JNK pathway. If cystatin F is involved in the JNK pathway or regulated by it, this can potentially enhance its activity. | ||||||